“You’ve spent time consulting dermatologists, trying treatments, and searching for answers about your skin concerns, especially during restless nights. If this resonates with you, know that you’re not alone in your journey”.
If that sounds familiar, you’re not alone.
Alopecia Areata affects thousands of adolescents across the country, and for many families, the path from diagnosis to finding real, meaningful support can feel uncertain and exhausting. The options available to teens have historically been limited — treatments designed for adults, little research focused specifically on adolescents, and no clear answers about what comes next. Alopecia Areata affects thousands of adolescents across the country, and for many families, the path from diagnosis to finding real, meaningful support can feel uncertain and exhausting. The options available to teens have historically been limited — treatments designed for adults, little research focused specifically on adolescents, and no clear answers about what comes next.
This study exists because researchers believe teenagers with severe alopecia areata deserve treatment options developed and tested for them — not adapted from adult data, but built around the specific needs of adolescent patients.
Right now, your family has the opportunity to be part of that work.
What does your family receive?
Participation in clinical research is a personal decision. Here’s what’s included for eligible families in this study.
A specialized program
Access to an investigational treatment approach being evaluated specifically for children under 12
Keep on Track
Close care and monitoring from a vitiligo specialist throughout the study
Reimbursements
Compensation for your time and reasonable travel expenses
Unlock answers for their unique skin
This research evaluates how well deuruxolitinib supports hair regrowth, how safe it is, and how it may affect eyebrows, eyelashes, and overall quality of life in adolescents with severe alopecia areata.
The study comprises a 24-week double-blind treatment phase, followed by a 52-week open-label extension, during which all participants receive the active medication. Subsequently, a 4-week follow-up period is conducted. The medication is administered orally twice daily.
Your privacy is important to us. Any information you provide through this website or during the eligibility screening process will be kept strictly confidential and used only for the purpose of evaluating potential participation in this research study.
Your child’s personal and medical information will be handled in accordance with applicable privacy laws and research regulations. Submitting your information does not obligate you to participate in the study.
Does your child meet the basic criteria?
Children may be eligible if they meet the following general conditions. A study team member will review your child’s full history during the screening process.
Basic eligibility criteria
Children under 18 years old at the time of enrollment.
White patches that appear on both sides of the body, not limited to one area.
Up to 50% of scalp hair loss, a doctor can help determine this request
Your child has been formally diagnosed of alopecia areata by a doctor.
What happens if we enroll?
Pre-screening
Complete a short form to see whether your child may be eligible based on basic criteria. No medical records needed at this stage.
Screening visit
If the pre-screen looks promising, you’ll meet with the study team in person. They’ll review your child’s history, examine the affected areas, and answer every question you have before any decisions are made.
Participation (if eligible)
Enrolled participants apply the investigational cream as directed and attend follow-up visits with the study team. Your child will receive close medical monitoring throughout, from vitiligo specialists.
Study Completion
The study team will walk you through what happens after the study ends, including next steps for your child’s ongoing care.
Why participate in a research study?
Clinical research plays a crucial role in providing children with access to new treatments and advancing medical knowledge for future generations. Our mission is to create new opportunities for children and families by advancing research and ensuring that they have access to innovative therapies that have the potential to transform lives.
Dr. Mercedes E. González
Pediatric Dermatology Specialist & Principal Investigator
What parents ask us most
Get straightforward explanations about how the research works, what it does, and how it supports your child’s health journey.
Your teen may qualify for this study.
If your child has severe alopecia areata and is between the ages of 12 and 17, find out in less than 2 minutes whether they may be eligible to participate — at no cost to your family.
Take less than 2 minutes · No commitment required · Our team reviews every response personally
8950 N. Kendall Drive, Suite 504, Miami, FL 33176 Phone: (305) 555-0100 Privacy Policy · Terms of Use · Contact Us ·
Legal Disclosure: This website is for informational purposes only and does not constitute medical advice. This is a research study — not everyone who is screened will qualify, and individual results cannot be guaranteed. The investigational medication has not been approved by the FDA for this indication. All study procedures require informed consent. Participation is voluntary and may be discontinued at any time.